Sacramento Invokana® Ketoacidosis Injury Lawyers
Our firm is investigating Invokana, Invokamet and other SGLT2 inhibitors on behalf of individuals who were prescribed these drugs and experienced serious health complications, ketoacidosis or kidney failure.
The Food and Drug Administration announced that it is reviewing the safety of all SGLT2 inhibitors, a new class of medication used to treat diabetes.
Sacramento pharmaceutical litigation attorneys at the Arnold Law Firm are ready to defend your rights. We are known for our strong background in class action lawsuits and dangerous drug litigation, and we have a successful track record of fighting and winning jury trials. Call our legal professionals today at (916) 777-7777 for your free case review.
FDA Invokana Warning
In December 2015, the U.S. Food & Drug Administration (FDA) announced that it would be requiring label changes on certain diabetes medications. The label changes would include warnings about the risk of too much acid in the blood and the risk of serious urinary tract infections. Too much acid in the blood and urinary tract infections could result in hospitalization.
On May 15, 2015, the U.S. Food & Drug Administration (FDA) issued a warning stating that Invokana and other similar diabetes medications has been linked to a serious health condition known as ketoacidosis, which may cause coma or death.
The FDA warning came in response to at least 20 reports of ketoacidosis in patients who took diabetes drugs from the sodium-glucose cotransporter-2 (SGLT2) inhibitor class. The latest announcement from the FDA reveal that approximately 73 cases of ketoacidosis were reported to the FDA's Adverse Event Reporting System (FAERS) between March 2013 and May 2015.
Signs of Ketoacidosis
Diabetic ketoacidosis (DKA) occurs when the body is unable to regulate ketone production. Ketones are natural chemicals that turn fat into energy when the body doesn't have enough insulin. Too many ketones can poison the body, causing a harmful level of acids in the blood.
DKA is more common in type-1 diabetes patients. Early signs include persistent feelings of thirst and frequent urination. High blood sugar levels and high levels of ketones in a patients urine are also indicators of DKA.
Urgent DKA symptoms requiring prompt medical attention include:
- Nausea, vomiting or pain in abdomen
- Difficulty breathing
- Fruity odor on breath
- Confusion or distraction
What is Invokana?
Invokana is a drug designed to inhibit SGLT2, a protein that transports glucose (blood sugar). Kidneys help filter waste products from the blood, including excessive blood sugar. Invokana works with the kidneys to help eliminate extra glucose from the body. The medication is used to help regulate blood sugar levels in adult patients with Type-2 diabetes. This class of drugs, however, is not approved to treat Type-1 diabetes patients.
Consumer protection group Institute for Safe Medication Practices (ISMP) not only linked Invokana to hundreds of severe adverse events within the first 12 months of its market release, it found the Invokana label does not warn patients of dangerous potential side effects.
The manufacturers and marketers of SGLT2 inhibitors (such as Johnson & Johnson, Janssen Pharmaceuticals Inc. and AstraZeneca) are accused of purposely withholding these health risks.
This includes but is not limited to:
- Increased risks of kidney failure
- Heart attacks (myocardial infarction)
- Cardiovascular issues
Contact our Sacramento Invokana Ketoacidosis Lawyers
Have you suffered from serious side effects after taking Invokana?
Our team of Sacramento defective drug lawyers is compassionate to victims of faulty products, and strongly believes that companies and corporations must be held responsible and accountable for their negligent actions.
At the Arnold Law Firm, your initial case review is free and we will fight to obtain the MAXIMUM amount of compensation that you may be eligible to receive. We also only get paid when we obtain a recovery or settlement for your claim.